Figure 2.

Lifetime risk of stages 3–5 CKD for men and women starting at age 45 years. CKD is defined as follows: (1) two consecutive measurements of eGFR<60 ml/min per 1.73 m², (2) development of treated kidney failure with dialysis or transplant (ESRD), (3) one measurement of eGFR<60 ml/min per 1.73 m² if the participant died before the next measurement, and (4) one measurement of eGFR<45 ml/min per 1.73 m² if it was the last eGFR.